BioCentury
ARTICLE | Clinical News

Avastin bevacizumab regulatory update

April 13, 2015 7:00 AM UTC

The European Commission approved an expanded label for Avastin bevacizumab in combination with standard chemotherapy to treat adults with persistent, recurrent or metastatic carcinoma of the cervix. T...